449 related articles for article (PubMed ID: 27611239)
1. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
2. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
3. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
5. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
7. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells.
Rivière J; Hauer J; Poirot L; Brochet J; Souque P; Mollier K; Gouble A; Charneau P; Fischer A; Pâques F; de Villartay JP; Cavazzana M
Gene Ther; 2014 May; 21(5):529-32. PubMed ID: 24622732
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
9. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750
[TBL] [Abstract][Full Text] [Related]
10. Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?
Cowan MJ; Gennery AR
J Allergy Clin Immunol; 2015 Nov; 136(5):1178-85. PubMed ID: 26055221
[TBL] [Abstract][Full Text] [Related]
11. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
[TBL] [Abstract][Full Text] [Related]
12. Lymphopoiesis in transgenic mice over-expressing Artemis.
Rivera-Munoz P; Abramowski V; Jacquot S; André P; Charrier S; Lipson-Ruffert K; Fischer A; Galy A; Cavazzana M; de Villartay JP
Gene Ther; 2016 Feb; 23(2):176-86. PubMed ID: 26361272
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
[TBL] [Abstract][Full Text] [Related]
14. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
[TBL] [Abstract][Full Text] [Related]
16. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.
Zhou S; Mody D; DeRavin SS; Hauer J; Lu T; Ma Z; Hacein-Bey Abina S; Gray JT; Greene MR; Cavazzana-Calvo M; Malech HL; Sorrentino BP
Blood; 2010 Aug; 116(6):900-8. PubMed ID: 20457870
[TBL] [Abstract][Full Text] [Related]
17. Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide.
Ijspeert H; Lankester AC; van den Berg JM; Wiegant W; van Zelm MC; Weemaes CM; Warris A; Pan-Hammarström Q; Pastink A; van Tol MJ; van Dongen JJ; van Gent DC; van der Burg M
Genes Immun; 2011 Sep; 12(6):434-44. PubMed ID: 21390052
[TBL] [Abstract][Full Text] [Related]
18. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
19. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP
Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]